Registration
 
All news
Top Stories
Editors' Picks
Stocks
Crypto
Economics
Currencies
Commodities
Business & Wealth
Market Voices
Mikhail Vnuchkov
Mikhail Vnuchkov

Castle Biosciences begins dual listing on Nasdaq Texas as CSTL expands presence

Castle Biosciences begins dual listing on Nasdaq Texas as CSTL expands presence
Castle Biosciences joins Nasdaq Texas

Castle Biosciences has commenced trading its common stock on Nasdaq Texas, marking a significant expansion in its market presence.

The company, which maintains its primary listing on The Nasdaq Global Market, began trading on the newly established exchange on August 17 under its current ticker symbol CSTL. Nasdaq Texas aims to serve as a new platform for listed companies, providing an additional avenue for liquidity and investor engagement.

Castle Biosciences recently outlined new approaches in advanced diagnostics and data innovation at the Future Biotech Expo 2026. The company’s chief operating officer has also detailed how local alliances supported its expansion in Greater Phoenix. These steps highlight recent milestones in Castle Biosciences' development.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

Binance hack: The biggest theft in crypto history
  • By Eugene Komchuk
  • 1 hour ago
Binance hack: The biggest theft in crypto history
Editors' Picks
From PlayStation to crypto: Why Sony is building its own blockchain
  • By Ksenia Gerey
  • 22 hours ago
From PlayStation to crypto: Why Sony is building its own blockchain
Editors' Picks
Google loses billions: What’s behind Alphabet’s stock crash?
  • By Oleg Tkachenko
  • Yesterday
Google loses billions: What’s behind Alphabet’s stock crash?
Editors' Picks
All Editors' Top Picks

Latest Castle News

Castle Biosciences unveils findings from three Barrett Esophagus studies at ACG 2026
  • By Oksana Koneva
  • 12.10.2026
Castle Biosciences unveils findings from three Barrett Esophagus studies at ACG 2026
Companies
#Castle
Castle Biosciences study finds TissueCypher Barrett Esophagus Test led to 90 percent change in clinician recommendations
  • By Alena Volkova
  • 28.09.2026
Castle Biosciences study finds TissueCypher Barrett Esophagus Test led to 90 percent change in clinician recommendations
Companies
#Castle
Castle Biosciences research finds patient demand for molecular testing in atopic dermatitis treatment
  • By Mikhail Vnuchkov
  • 25.09.2026
Castle Biosciences research finds patient demand for molecular testing in atopic dermatitis treatment
Companies
#Castle
All Castle News
  • Eugene Komchuk
  • 1 hour ago
Binance hack: The biggest theft in crypto history
  • Ksenia Gerey
  • 22 hours ago
From PlayStation to crypto: Why Sony is building its own blockchain
  • Oleg Tkachenko
  • Yesterday
Google loses billions: What’s behind Alphabet’s stock crash?
  • Olena Litvinenko
  • Yesterday
The end of Bitcoin’s growth era: Why prominent investors doubt its future
  • Eugene Komchuk
  • Yesterday
WeFi CEO: Banks are overstating the threat from stablecoins
  • Hanna Syniavska
  • 5 min ago
Robert Colvile: Borrowing for defence still adds to spending levels
  • Eugene Komchuk
  • 15 min ago
Ki Young Ju: Coinbase Premium drops to lowest level in four years
  • Elena Nikulina
  • 18 min ago
Sam Ro: Crypto exchange hack and betting platform suspension affect part of economy
  • Yulia Slavina
  • 20 min ago
Anas Alhajji: Brent trades above $116
  • Pavlo Kot
  • 45 min ago
Attackers used compromised laptop to access exchange systems, Quinten Francois notes
Top News
  • Eugene Komchuk
  • 1 hour ago
Binance hack: The biggest theft in crypto history
Binance hack: The biggest theft in crypto history
  • Pavlo Kot
  • 1 hour ago
Polymarket resumes trading after $2.65 million hack
Polymarket resumes trading after $2.65 million hack
  • Olga Shendetskaya
  • 1 hour ago
De Cos and Knot emerge as front-runners to succeed Lagarde at ECB
De Cos and Knot emerge as front-runners to succeed Lagarde at ECB
  • Eugene Komchuk
  • 2 hours ago
Crypto liquidations exceed $1.5 billion following Binance hack
Crypto liquidations exceed $1.5 billion following Binance hack
  • Pavlo Kot
  • 11 hours ago
Binance hit by suspected $6 billion hack in potentially largest crypto attack ever
Binance hit by suspected $6 billion hack in potentially largest crypto attack ever
Live News
  • Eugene Komchuk
  • Now
Kia shares plunge 12% as Middle East war drives up costs
  • Igor Krasulya
  • Now
RBI urges lenders to strengthen defenses against AI-powered cyberattacks
  • Mykhailo Ihnatenko
  • Now
Ethereum price rebounds from oversold levels after Binance-driven selloff
  • Anton Kharitonov
  • Now
EUR/USD remains in a strong downtrend as ECB decision approaches
  • Jose Antonio Gastelum
  • Now
Cardano Foundation expands role in Swiss tokenized securities market
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org https://gdpr.eu/ GDPR World Association of News Publishers